Funding
Funding not disclosed
Founders
Product
Problem
Identifying specific disease markers within the vast complexity of whole genome data is a significant challenge. This complexity hinders the timely and accurate assessment of individual disease risks and the development of personalized health strategies.
Solution
Eden provides an AI-driven platform that performs real-time analysis of whole genome multi-omics data to identify up to 21 distinct disease markers. This capability enables the generation of proactive health insights and facilitates personalized risk stratification for individuals. The platform's AI agent is designed to scan entire genomes, offering a comprehensive approach to understanding an individual's predisposition to various conditions. By pinpointing these markers, Eden empowers users and healthcare providers with actionable information for preventative care and tailored health management plans.
Target Audience
The primary target audience includes individuals seeking advanced health insights and personalized risk assessments, as well as healthcare providers and researchers focused on precision medicine and early disease detection.
Features
- Real-time whole genome scanning utilizing an AI agent.
- Detection of up to 21 specific disease markers.
- Multi-omics data integration for comprehensive analysis.
- Generation of proactive health insights.
- Facilitation of personalized disease risk assessment.